tiprankstipranks
Kaken Pharmaceutical Co Ltd (KKPCF)
OTHER OTC:KKPCF
Holding KKPCF?
Track your performance easily

Kaken Pharmaceutical Co (KKPCF) Financial Statements

4 Followers

Kaken Pharmaceutical Co Financial Overview

Kaken Pharmaceutical Co's market cap is currently ―. The company's EPS TTM is $3.22; its P/E ratio is 8.97; and it has a dividend yield of 4.42%. Kaken Pharmaceutical Co is scheduled to report earnings on January 31, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 18.75B-$ 18.20B$ 18.33B$ 20.12B
Gross Profit$ 10.18B-$ 10.04B$ 9.56B$ 11.02B
EBIT$ 4.42B-$ 4.01B$ -567.00M$ 5.03B
EBITDA$ 4.42B-$ 4.01B$ -567.00M$ 5.03B
Net Income Common Stockholders$ 3.19B-$ 2.91B$ -697.00M$ 3.52B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 70.56B$ 0.00$ 73.70B$ 74.62B$ 66.96B
Total Assets$ 167.77B-$ 165.10B$ 165.18B$ 167.68B
Total Debt$ 3.85B$ 0.00$ 3.85B$ 3.85B$ 3.85B
Net Debt$ -66.71B$ 0.00$ -69.85B$ -70.77B$ -63.11B
Total Liabilities$ 27.07B-$ 27.25B$ 26.86B$ 27.99B
Stockholders Equity$ 140.12B$ 0.00$ 137.28B$ 137.75B$ 139.11B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Kaken Pharmaceutical Co Earnings and Revenue History

Kaken Pharmaceutical Co Debt to Assets

Kaken Pharmaceutical Co Cash Flow

Kaken Pharmaceutical Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis